Objective: Contingency management (CM) effectively treats addictions by providing abstinence incentives. However, CM fails for many who do not readily become abstinent and earn incentives. Shaping may improve outcomes in these hard-to-treat (HTT) individuals. Shaping sets intermediate criteria for incentive delivery between the present behavior and total abstinence. This should result in HTT individuals having improving, rather than poor, outcomes. We examined whether shaping improved outcomes in HTT smokers (never abstinent during a 10-visit baseline). Method: Smokers were stratified into HTT (n ϭ 96) and easier-to-treat (ETT [abstinent at least once during baseline]; n ϭ 50) and randomly assigned to either CM or CM with shaping (CMS). CM provided incentives for breath carbon monoxide (CO) levels Ͻ4 ppm (approximately 1 day of abstinence). CMS shaped abstinence by providing incentives for COs lower than the 7th lowest of the participant's last 9 samples or Ͻ4 ppm. Interventions lasted for 60 successive weekday visits. Results: Cluster analysis identified 4 groups of participants: stable successes, improving, deteriorating, and poor outcomes. In comparison with ETT, HTT participants were more likely to belong to 1 of the 2 unsuccessful clusters (odds ratio [OR] ϭ 8.1, 95% CI [3.1, 21]). This difference was greater with CM (OR ϭ 42, 95% CI [5.9, 307]) than with CMS, in which the difference between HTT and ETT participants was not significant. Assignment to CMS predicted membership in the improving ( p ϭ .002) as compared with the poor outcomes cluster. Conclusion: Shaping can increase CM's effectiveness for HTT smokers.
Smoking can be effectively treated with contingency management (CM) to reinforce abstinence (Volp et al., 2009 ; also see Sigmon, Lamb, & Dallery, 2008) . However, those who do not readily initiate abstinence in such programs frequently do not earn incentives and do not do well (Higgins et al., 2006; . suggested that shaping might be used to set intermediate criteria for incentive delivery between the present behavior and total abstinence and, thus, make CM more effective for hard-to-treat (HTT) smokers (i.e., those who do not stop smoking immediately before or immediately after treatment begins). This is because HTT smokers are less likely to be abstinent during CM, and if CM works by reinforcing abstinence and abstinence never occurs, it is never reinforced. Thus, CM should not be as effective in HTT smokers. Shaping may improve CM in HTT smokers, as it works by reinforcing successive approximations of the desired behavior until the desired behavior ultimately occurs. Thus, by reinforcing reduced smoking or shorter periods of abstinence, the longer periods of abstinence typically reinforced in CM might be shaped, and CM's effectiveness in HTT smokers should be increased.
Over the last several years, we developed a means to shape smoking cessation that uses percentile schedules Lamb et al., 2007) . These provide incentives if the current behavior is more similar to the desired behavior than some percentage of recent behaviors (Galbicka, 1994) . For example, rather than requiring complete abstinence for incentive delivery, one could require that the current carbon monoxide (CO) sample (a measure of smoking in the last day) be less than any of the previous 9 days. A sample that meets this criterion would be the sample nearest to abstinence of the last 10 samples collected-that is, it was better than nine of the last 10 samples, and such a sample would occur 10% of the time. This is a fairly stringent criterion, but it does not require complete abstinence for incentive delivery. By adjusting the number of previous samples that the present sample must be better than, any probability of earning an incentive can be achieved. Thus, if the current sample must be better than only three of the last nine samples (i.e., among the seven best of the last 10 samples), it will do so 70% of the time (producing an incentive on this same 70%). Percentile schedules, thus, deliver incentives following an individual's better behavior. As the individual's behavior changes, the percentile criterion remains constant, but the CO level that corresponds to that criterion changes as the samples comprising the comparison distribution changes. We have found that with HTT smokers, making it more likely that an individual earns incentives (e.g., as with the 70th percentile schedule just described) is more effective than making it more difficult for the individual to earn an incentive (e.g., requiring the current sample to be better than all of the last nine; . Recently, we showed that percentile schedules could shape reduced smoking and increase abstinence in smokers without plans to quit (Lamb et al., 2007) .
In the present study, we examine whether CM with shaping (CMS) improves outcomes of HTT smokers compared with CM alone. We stratified smokers into HTT and easier-to-treat (ETT; those abstinent for at least 1 day during a 10-visit preintervention period) groups, and we randomly assigned them to either CMS or CM. After the 60-visit intervention, we analyzed daily CO samples using cluster analysis to identify four types of treatment response: stable success, improving, deteriorating, or poor (see Morral, Iguchi, Belding, & Lamb, 1997) . As ETT participants were able to be abstinent prior to randomization, we expected them to perform well with either CM or CMS. On the other hand, HTT participants have difficulty initiating abstinence and thus earning an incentive. By bringing the HTT participants into contact with incentives for reduced smoking, we expected CMS to improve outcomes for HTT participants in comparison with CM. In particular, relative to CM, CMS should increase the proportion of HTT participants having improving rather than poor outcomes. Because HTT participants start off poorly, they are not expected to be found in either the stable success or the deteriorating groups.
We hypothesized the following: (a) that relative to CM, CMS increases the odds that individuals belong to the improving as opposed to the poor outcomes cluster, and (b) any improved outcomes in CMS relative to CM are due to the improvements in the HTT participants; (c) that ETT participants do better than HTT participants, with a greater proportion of ETT participants belonging to one of the two successful clusters; and (d) that with CMS, this difference between ETT and HTT participants is smaller. We did not expect CMS and CM to differ in the ETT participants; however, this experiment was not designed to test the equivalency of CMS and CM in ETT participants.
Method Participants
Participants were Ն18 years of age, smoking Ն15 cigarettes per day, seeking to quit smoking, and willing to deliver a breath sample each weekday for up to 4 months. A breath CO Ն 15 ppm at intake was also required. Participants were recruited through flyers, by word of mouth, and by occasional news stories between January 2002 and January 2005. A total of 186 individuals provided informed consent (see Figure 1 ). Of these, 146 completed the 10-visit baseline and were randomized. Participants leaving before randomization were similar to those randomized. About half left without explanation, whereas the remainder cited difficulties with daily attendance. One individual decided the study was not likely to be helpful. The University of Texas Health Science Center at San Antonio Institutional Review Board approved this study.
Measures
We measured breath CO levels using a CO monitor (Vitalograph Inc., Lenexa, KS). Participants took a deep breath, held it for 20 s, and then expired into a disposable mouthpiece. The peak reading was recorded. We used a CO abstinence criterion of 4 ppm because previous work (Javors, Hatch, & Lamb, 2005) indicated that this criterion has a specificity of 0.945.
During a half hour intake session immediately following informed consent, the Fagerström Test of Nicotine Dependence (FTND; Heatherton, Kozlowski, Frecker, & Fagerström, 1991) , the Contemplation Ladder (CL; Biener & Abrams, 1991) , and the Confidence Questionnaire (CQ; Condiotte & Lichtenstein, 1981) were collected. The FTND consists of six items that produce a score ranging from 0 to 10. The CL is an 11-point anchored visual analog scale assessing readiness to quit smoking, and it has demonstrated good predictive validity (Biener & Abrams, 1991) , convergent validity (Amodei & Lamb, 2004) , and reliability (Rustin & Tate, 1993) . The CQ is a 14-item self-efficacy measure. It is a short version of the original (Baer & Lichtenstein, 1988) , which has high internal reliability (␣ ϭ .99), and it requires smokers to rate the probability that they would be able not to smoke in a range of situations. The score is the average of these 14 ratings and can range from 0 to 100. In addition, we collected demographic information and smoking histories using internally developed instruments.
Baseline Assessment, Randomization, and Interventions
The study consisted of 70 visits on successive weekdays, excluding holidays: a 10-visit preintervention period followed by a 60-visit intervention period. This took around 3-3.5 months and was similar in length to many smoking cessation trails (e.g., Yudkin, Jones, Lancaster, & Fowler, 1996) and CM trials (e.g., Higgins et al., 1994) . Excused absences could be prearranged with 24-hr advance notice. In emergencies, shorter advanced notice was allowed. Visits were scheduled at a mutually determined time between 11:00 a.m. and 5:30 p.m. Participants met with a research assistant and (a) delivered a CO sample, (b) reported the number of cigarettes smoked in the last day, and (c) signed a receipt for money received. Participants earned $1.00 for each visit, which took about 5 min. No counseling was provided at these visits or by us at any other time.
Ten-visit preintervention period. On Visit 1, participants could earn $2.50 for a CO Ͻ 4 ppm. They were told this could be obtained by not smoking for a day. For Visits 2-10, no contingencies were in effect. Participants were told that this was so we could see how they were doing on their own. Participants were classified as ETT (n ϭ 50) or HTT (n ϭ 96) on the basis of whether they delivered one or more CO Ͻ 4 ppm during this period. The mean baseline CO in the HTT participants was 18.1 (SD ϭ 7.5) compared with 6.3 (SD ϭ 5.3) in the ETT participants-of whom nine delivered a single CO Ͻ 4 ppm, 20 delivered 2-5 COs Ͻ 4 ppm, 15 delivered 6 -9 COs Ͻ 4 ppm, and six delivered 10 COs Ͻ 4 ppm during baseline. Previous work showed that those delivering a CO Ͻ 4 ppm during this period are more likely to do well during the intervention .
Randomization. Following the 10-visit preintervention period, we randomized participants to either CM or CMS using a multistep procedure. First, participants were categorized as either ETT or HTT. Second, HTT and ETT participants were categorized on whether at intake they reported intending to use a smoking cessation medication; this created four categories: HTTmedication, HTT-no medication, ETT-medication, and ETT-no medication. We then randomly assigned individuals within each of these categories to CMS or CM using a blocking procedure accounting for order of study entry. A research assistant told each participant on Visit 10 which group they had been assigned to, as it was not possible to blind participants to treatments given the nature of the interventions.
CM. Incentives were available on each of the 60 intervention visits for delivering a CO Ͻ 4 ppm. We set the incentive amount using an escalating payment schedule (Higgins et al., 1994) . Incentives began at $2.50 and increased by $0.50 with each criterion sample. The delivery of five consecutive criterion samples resulted in a $10.00 bonus. When a sample did not meet criterion, the next available incentive reset to $2.50. After a reset, the delivery of five consecutive criterion samples resulted in the incentive being returned to the highest amount earned. The maximum that could be earned under this schedule with either CM or CMS was $1,157.50.
CMS. CMS was identical to CM, except that the incentive criteria were set with a percentile schedule (Galbicka, 1994) . Participants earned incentives whenever a CO was Ͻ4 ppm, or when it was below the seventh lowest of the last nine observations. This moving criterion kept the criterion within the range of recently observed behavior for a given person (i.e., not exceeding their demonstrated abilities) while providing incentives for submitting lower CO levels. Participants were told on each visit the CO criterion for their next visit. They were given no specific information about how these criteria were set. 
Data Analysis
Three sets of analyses were conducted. The first compared characteristics of participants in the two interventions, and it examined attendance, incentive delivery rates, and amounts earned. The second developed the outcome clusters central to our hypotheses. The third examined our specific hypotheses: (a) that relative to CM, CMS increases the odds that individuals belong to the improving as opposed to the poor outcomes cluster, and any improved outcomes in CMS are because (b) outcomes are generally better for the HTT-CMS than the HTT-CM; (c) that ETT participants do better than HTT participants with a greater proportion of ETT participants belonging to one of the two successful clusters; and (d) that with CMS, this difference between ETT and HTT participants is smaller. Finally, in the ETT participants, we also compared outcomes between CMS and CM, but we did not have specific hypotheses about these differences. We conducted these outcome comparisons both using cluster analysis, which can produce powerful and meaningful outcome measures but can be sample dependent, and with outcome measures that were not sample dependent. We conducted all analyses using STATA (Version 10) on a Macintosh computer.
Participant characteristics, attendance, incentive delivery rates, and amounts earned. We compared participant characteristics using t tests with a Welch correction, median tests, Fisher's Exact tests for 2 ϫ 2 tables, and chi-square tests for larger tables. Incentive contact was compared between the CM and CMS groups for the HTT and ETT subgroups separately (a) to determine whether CMS improved contact in the HTT participants and ensured contact on Ն70% of visits for the HTT as it was theoretically designed to do and (b) to examine whether in ETT participants contact was similar between groups. We used Fisher's Exact and median tests. Amounts earned were examined similarly.
Clustering procedure. We expected CMS to change the cluster membership of the HTT participants, such that instead of falling in the poor outcomes cluster, more HTT participants would be classed among those with improving outcomes. We categorized participants into different outcome groups using cluster analysis based on the number of COs Ͻ 4 ppm during each set of 10 sequential visits during the 60-visit intervention phase-that is, during [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] This provided a way to examine the temporal pattern of delivery of COs Ͻ 4 ppm. We used methods similar to those described in Morral et al. (1997) , forming clusters using Ward's agglomeration and squared Euclidean distances. We examined solutions having from two to six clusters, as solutions with more than six clusters had too few members to be useful. The four-cluster solution appeared optimal. As can be seen in Figure 2 , it consisted of a stable success (n ϭ 66), an improving (n ϭ 9), a deteriorating (n ϭ 19), and a poor outcome cluster (n ϭ 52), essentially replicating another study of CM in methadone-maintenance patients (Morral et al., 1997) . The four-cluster solution also provided the clusters needed to test our primary hypothesis that relative to CM, CMS would increase the odds of belonging to the improving cluster rather than to the poor outcomes cluster. The four clusters did not differ from each other on any participant characteristic in Table 1 , except longest time without smoking and FTND. Although the overall analysis of variance indicated differences in longest time without smoking, none of the between-groups comparisons were significant. Those in the stable success cluster had lower FTND scores than those in the deteriorating cluster, t(82) ϭ 2.9, p Ͻ .05, or the poor outcomes cluster, t(114) ϭ 2.8, p Ͻ .05.
The two-and three-cluster solutions were suboptimal because they produced a highly heterogeneous cluster consisting of what would become the improving, deteriorating, and/or poor outcomes clusters. The five-and six-cluster solutions were potentially useful. The five-cluster solution broke out an early improving cluster from the stable successes. To ensure that our conclusions were not an artifact of selecting the four-over the five-cluster solution, we reran all our analyses using the five-cluster solution with essentially identical results. The six-cluster solution broke out a rapid deteriorating cluster from the poor outcomes cluster. For the questions posed, the six-cluster solution would have identical results to the five-cluster solution.
Comparisons of outcomes. Intent to treat analyses were conducted including all randomized participants. As the outcome measures were all based on whether a scheduled CO sample was Ͻ4 ppm, there were no missing data: A sample that was scheduled, but not delivered, was counted as not Ͻ4 ppm. Probabilities of Ͻ.05 of the null hypothesis being true were considered significant.
To examine how membership in the improving versus the poor outcomes cluster or in the stable success and improving versus the deteriorating and the poor outcomes clusters were influenced by either treatment (CM vs. CMS) or group membership (ETT vs. HTT), we calculated odds ratios (ORs) using logistic regression procedures. When necessary, we tested differences in proportions using Fisher's Exact test. Additional analyses were conducted to confirm that these results were not sample dependent. In par- ticular, we also examined two noncluster outcomes: number of visits with a breath CO Ͻ 4 ppm and delivery of a CO Ͻ 4 ppm on each visit during Visits 66 -70. We examined these using the median test and by calculating ORs. We looked at the influence of covariates on these outcomes as described below. In doing this, analysis of variance procedures were substituted for the median test.
We examined the influence of variables listed in Table 1 on these outcomes. This was done in a multistaged process. First, we examined the influence of all the variables in Table 1 together. Any having a p Ͻ .15 were included in subsequent analyses, as were variables that differed between any of the subgroups reported in Table 1 that had a p Ͻ .30. Membership in the improving as opposed to poor outcomes was treated slightly differently because of the limited number of participants. We examined demographic, current smoking, and smoking history variables in three separate analyses and chose variables for subsequent analyses according to the criteria above. This permitted a manageable number of covariates to be examined. We then included all these covariates in the analyses testing our hypotheses, and the adjusted results are reported. The unadjusted results were similar to the adjusted results. The only outcome measure for which the effects of covariates could not be examined directly was membership in the improving cluster rather than the poor outcomes cluster comparing CMS versus CM. This was because all those in the improving cluster received CMS. However, none of the potential covariates predicted membership in the improving cluster as compared with the poor outcomes cluster. Note. We compared means using the Welch test. We compared medians using a median test. We examined 2 ϫ 2 tables using Fisher's Exact test, and we examined larger tables using a chi-square test. ETT ϭ easier-to-treat; HTT ϭ hard-to-treat; CM ϭ contingency management; CMS ϭ CM with shaping; HS ϭ high school; GED ϭ graduate equivalency degree; BAϩ ϭ bachelor's degree or higher; VoTech ϭ completed trade school; AA ϭ associates degree; CO ϭ carbon monoxide; FTND ϭ Fagerström Test of Nicotine Dependence. a Self-reported race/ethnicity. b Income data from one participant was not collected. c Data are missing for four participants. d Number for whom smoking was allowed at work/number responding. ‫ء‬ p Ͻ .05.
Results

Participants
Average participant age was just less than 40 years (see Table  1 ). About two thirds were Caucasian and non-Hispanic, about 15% were Hispanic, and about 40% were female. Approximately 40% were married, and two thirds had some education beyond high school. On average, participants smoked just over a pack per day, started between 14 and 15 years of age, and began smoking regularly between 16 and 18 years of age. Half had between two and five previous quit attempts. About one third planned on using cessation medications.
As expected, HTT participants were different from ETT participants in several ways. They were older, had lower CQ scores, and were more likely to have smoking permitted at work. HTT participants also had fewer smoke-free days in the past year and higher intake COs and FTND scores. HTT-CM and HTT-CMS participants did not differ, which strengthens conclusions that can be drawn from hypothesis testing focusing on these two subgroups alone. Some differences were observed between ETT-CM and ETT-CMS participants (see Table 1 ).
Attendance and Incentive Contact
The median number of visits attended was 69 out of 70 (interquartile range [IQR] ϭ 40 -70). For all subgroups, the medians were 70, except for the HTT-CM participants (Median ϭ 65.5). Nonattendance for individuals can be seen by looking for blank spaces in Figure 3 .
CMS is designed to provide incentives on 70% or more of visits, and increased incentive contact in the HTT participants is the mechanism by which CMS is postulated to improve outcomes in the HTT participants. Thus, it is important to assess whether CMS improves contact over CM in the HTT participants and that this level of contact is close to what CMS was designed to provide. Every HTT-CMS participant earned an incentive (48/48), but only 63% (30/48) of HTT-CM participants did (Fisher's Exact test, p Ͻ .001). The median number of incentives earned by HTT-CM participants was 3.5, and it was 44 in HTT-CMS participants: median test 2 (1, N ϭ 96) ϭ 12.0, p Ͻ .001. CMS was designed to provide incentives on 70% or more of visits, and 44 of 48 (92%) HTT-CMS participants met this criterion compared with only 17 of 48 (35%) of HTT-CM participants (Fisher's exact test, p Ͻ .001). Of the four HTT-CMS participants earning incentives on fewer than 70% of visits, all earned an incentive on Ͼ60% of visits. Among HTT-CM participants, 24 of 48 (50%) earned incentives on 10% or fewer visits.
Although CMS increased incentive contact among the HTT participants, incentive contact was similar in the ETT-CM and ETT-CMS participants. Every ETT participant earned an incentive. The median earned for ETT-CM participants was 57 (IQR ϭ 48 -59), and for ETT-CMS participants, the median earned was 58 (IQR ϭ 50 -59). Only two of 25 in CM, and one out of 25 in CMS, earned an incentive on fewer than 70% of their visits.
Maximum possible incentive earnings were $1,157.50, and the median was $486 (see Table 2 ). Three points directly related to number of incentives earned can also be discerned: (a) ETT participants earned more the HTT participants; (b) participants receiving CMS earned more than participants receiving CM; and (c) as would be expected from the incentive contact data reviewed above, HTT-CMS participants earned more that HTT-CM participants, whereas ETT-CMS and ETT-CM participants earned similar amounts.
Treatment Outcomes
CMS versus CM. Individuals in CM and CMS had similar likelihoods of being abstinent at end of treatment (38% vs. 47%) and numbers of COs Ͻ 4 ppm (Medians ϭ 30 [IQR ϭ 1-59] for CM vs. 35 [IQR ϭ 6 -54] for CMS) during treatment. When outcome clusters were collapsed, those receiving CMS were sig- Figure 3 . Event records for each individual grouped together into clusters. Top panel presents data for the easier-to-treat participants, who had a carbon monoxide (CO) level Ͻ4 ppm before the start of the interventions at Visit 11. Bottom panel presents data for the hard-to-treat participants, who did not have a CO level Ͻ4 ppm before the start of the intervention. Dark spaces represent breath CO levels Ͻ4 ppm, whereas lighter spaces represent breath CO levels Ն4 ppm. Empty spaces represent missed visits. The horizontal axis is sequential visits, and each "line" of data represents an individual participant. The vertical line in each column separates the 10th and 11th visit and indicates when the experimental contingencies went into effect. The left column is participants receiving contingency management (CM), and the right column is participants receiving CM with shaping (CMS).
nificantly more likely than those receiving CM to belong to the stable success or improving cluster (56% vs. 47%; OR ϭ 2.6, 95% CI [1.1, 6.2]). This was specifically due to significantly higher membership of CMS in the improving category (0% CM vs. 12% CMS), as can be seen in Figure 3 and in Tables 3 and 4. HTT-CM versus HTT-CMS. The differences between CMS and CM were a result of differences between the HTT-CMS and HTT-CM participants. In the HTT participants, relative to CM, CMS increased the odds of being abstinent at the end of treatment (see Table 4 ). The HTT-CMS and HTT-CM participants did not differ in the number of visits with a CO Ͻ 4 (see Tables 3 and 4) . Among the HTT participants, CMS had a higher proportion belonging to the stable success and improving clusters than CM (see Tables 3 and 4) . As can be seen in Figure 3 , this was a result of those receiving CMS being more likely than those receiving CM to belong to the improving cluster rather than to the poor outcomes cluster (see Table 4 ).
ETT versus HTT. A larger proportion of ETT than HTT participants were abstinent at the end of treatment (see Tables 3  and 4 ). This was the case with CM (OR ϭ 6.9, 95% CI [1.9, 25]), but it was significantly less and not significant with CMS (OR ϭ 1.6, 95% CI [0.5, 5.3]). The ETT participants had more visits with a CO Ͻ 4 ppm than the HTT participants (see Tables 3 and 4) . This difference was large: 75% of the ETT participants had 43 or more visits delivering a CO Ͻ 4 ppm, whereas 75% of the HTT participants had less than 44 visits delivering a CO Ͻ 4 ppm. This difference between ETT and HTT participants was significant in both the CM and CMS groups (see Table 3 ). As can be seen by comparing the top and bottom panels of Figure 3 , when outcome clusters were collapsed, the ETT participants were more likely than the HTT participants to belong to stable success or improving clusters (see Table 4 ). This OR was greater in those receiving CM (OR ϭ 42, 95% CI [5.9, 307]) than in those receiving CMS (OR ϭ 4.0, 95% CI [0.9, 17]), for whom the OR was nonsignificant. Thus, the ETT participants receiving CM did better in treatment than the HTT participants receiving CM, but this difference was smaller and often not significant in those receiving CMS.
ETT-CMS versus ETT-CM. None of the outcomes examined differed between the ETT-CMS and the ETT-CM participants. They did not differ in their likelihood of being abstinent at the end of treatment, in the number of visits with a CO Ͻ 4 ppm, or in their likelihood of belong to the stable success or improving clusters.
Discussion
Shaping makes CM more effective for HTT smokers who are least likely to respond well to abstinence-oriented CM. Abstinence-oriented CM is effective at facilitating smoking cessation (Sigmond et al., 2008) ; however, like all effective treatments, it fails for many. These HTT individuals can often be identified early on by their failure to meet the abstinence criterion. In abstinence-oriented CM, this means they do not receive the available incentives designed to reinforce abstinence and increase its future frequency. As reinforcement of abstinence is the pre- Note. ETT ϭ easier-to-treat; HTT ϭ hard-to-treat; CM ϭ contingency management; CMS ϭ CM with shaping; CO ϭ carbon monoxide. ‫ء‬ p Ͻ .05 (Fisher's Exact or median test).
sumed active ingredient of CM, treatment failure is both understandable and predictable for these smokers. Shaping provides incentives for successive approximations of the desired behavior-in this case longer and longer periods of abstinence (as reflected by lower CO levels). This ensures incentive delivery following behavior closer to the desired behavior (Galbicka, 1994) , even in the absence of complete abstinence early in treatment. Shaping improved outcomes for HTT participants but not ETT participants, as ETT participants were able to meet the abstinence criterion even before treatment began. Treatment success in general (Yudkin et al., 1996) and with CM in particular can often be predicted on the basis of the rapid initiation of abstinence. In the present study, the ETT-CM participants had 42-fold greater odds of a successful outcome than did the HTT-CM participants. Individuals rapidly initiating abstinence are more likely to come into contact with the programmed incentives of CM, as well as with the natural positive consequences of abstinence, and to do so sooner than those in whom abstinence is delayed or fails to occur. The units of abstinence that are reinforced (usually 1 day, 1 week, or 2 weeks) are much shorter than the units of abstinence that are taken as a measure of success (1 month, 3 months, 1 year, etc.). Reinforcing these smaller units increases their frequency and builds the larger units by which we measure success. Those who succeed in CM often exhibit these smaller units that will earn incentives even before incentive delivery begins. However, without effective treatment, the likelihood that these smaller units increase in frequency to become the larger units by which we measure success is small (Morral et al., 1997) . In large part, effective treatments work by facilitating the longer term success of ETT participants. The HTT participants differed from the ETT participants in several ways. The HTT participants were more dependent and had fewer days without smoking in the past year. They also were more likely to have workplaces permitting smoking and were less confident in their ability to refrain from smoking. Thus, the HTT participants in this study were similar to those who in other studies are less successful in stopping their smoking. Further, other studies of CM (e.g., Higgins et al., 2006) and of nicotine replacement therapies (e.g., Yudkin et al., 1996) found that smokers who did not rapidly initiate abstinence at the beginning of treatment were very likely to do poorly. Thus, it is remarkable that CMS improved outcomes for the HTT participants. Still, CMS moved only seven individuals into the improving cluster, and this might at first seem to be a modest effect. However, the result of this was that 46% of the HTT participants receiving CMS had a good outcome as opposed to 27% of the HTT participants receiving CM, resulting in a 70% improvement in the number of HTT participants having good outcomes.
One element of CMS that likely enhanced the effectiveness of the percentile schedule was its use in conjunction with an escalating payment schedule. Each sequential incentive delivery increased the magnitude of the next available incentive, and failure to meet the criterion reset incentive value to its starting amount. Roll and colleagues (Roll & Higgins, 2000; Roll, Higgins, & Badger, 1996) showed that escalating payment schedules increase the likelihood of continuing to meet the reinforcement criterion once it has been met. As percentile schedules guarantee that an individual meets the reinforcement criterion, and the escalating payment schedule increases the probability that once it is met it continues to be met, these two elements of CMS work together to facilitate continued smoking reductions. When the percentile schedule reduces smoking such that further reduction results in abstinence, the escalating payment schedule dictates that the incentive available for abstinence be larger than it was initially. Numerous studies show that larger incentives are more effective at promoting abstinence (e.g., Stitzer & Bigelow, 1984) .
There are limitations of the CMS intervention. As with CM, some individuals were in the deteriorating cluster. The deteriorating cluster consisted of similar numbers of those receiving CMS or CM. Participants initiated abstinence under both interventions, but they failed to maintain abstinence over time in treatment. This pattern of behavior suggests that both groups might benefit from additional relapse prevention interventions from a different escalating schedule (Roll & Higgins, 2000; Roll et al., 1996) or possibly from delaying their quit attempt while gradually reducing their smoking. All of these possibilities merit further investigation.
There are potential limitations to this study. First, this study was not designed to detect differences in abstinence rates at posttreatment follow-up. Detecting such differences would have required substantially more participants, and we decided to first test the utility of shaping abstinence during treatment, given the strong relationship between outcomes during treatment and at follow-up for CM treatments (Higgins, Badger, & Budney, 2000; Higgins et al., 2006) . Given the positive results of this study, larger studies examining posttreatment follow-up abstinence rates of CMS and CM are merited, as the cost effectiveness of these interventions and their relative cost effectiveness depends on how long the effects of these treatments endure.
Second, although we believe this study provides compelling evidence that shaping can improve outcomes among HTT smokers, contingently reinforcing breath CO levels may not be practical in many settings as a smoking cessation treatment. The intervention involved 70 daily visits and may appear burdensome, limiting its general application and exerting a selection bias on participation. Although the visits were short-about 5 min-the near daily nature of these means that most participants would need to live or work near the treatment site. We did not track the number of individuals who decided not to schedule a meeting for informed consent because of this potential burden. Of the 186 participants providing informed consent, 22% dropped out in the approximately 2 weeks of daily visits before the intervention began. Almost all of those who provided a reason cited the burden of the daily visits.
Although self-reports of smoking are typically more easily collected, their reliability in the context of a CM intervention is doubtful, making in-person deliveries of more objective breath samples important. Using a low CO cutoff (e.g., Ͻ4 ppm) on afternoon samples results in these being adequate measures of smoking in the last day (Javors et al., 2005) , but it requires near daily measurement in CM. Less frequent monitoring is necessary when cotinine levels are measured. However, monitoring cotinine is more costly, takes more time to analyze, is confounded by nicotine replacement therapies, and still requires measurement at least twice a week. The requirement for frequent visits suggests some contexts in which this intervention might be practical. In particular, worksite implementation or implementation in more densely populated urban areas would seem promising. Alternatively, remote monitoring technology has been used as a way to reduce the burden of participating in CM interventions for smoking cessation (Dallery & Glenn, 2005) .
An alternative to shaping is using high initial payments. We and others have shown that smoking abstinence Stitzer & Bigelow, 1984) increases as the incentive available increases. With sufficient incentives, abstinence initiation rates can be quite high (e.g., 75%). Stitzer and her colleagues (e.g., Robles et al., 2000) suggested that combining high payment amounts with easier initial response requirements might result in higher initial abstinence rates. Kirby, Marlowe, Festinger, Lamb, and Platt (1998) showed that using initially high incentive amounts and short abstinence requirements that changed to smaller incentive amounts and longer abstinence requirements as these were met could result in an effective treatment for cocaine addiction. These procedures and the shaping procedure described here all increase the likelihood that some period of abstinence earns an incentive that can potentially reinforce abstinence and increase its future probability. Given the results of Kirby et al. and this study, shaping procedures may further improve CM outcomes.
Shaping improved outcomes for those least likely to do well in CM in this smoking cessation study. Shaping is likely to prove useful in the treatment of other addictions as well. Preston, Umbricht, Wong, and Epstein (2001) and Kirby et al. (1998) showed its potential utility in treating cocaine addiction. Extending shaping to other interventions focusing on increasing or decreasing a single behavior that can be measured ordinally would be straightforward. For instance, Athens, Vollmer, and Pipkin (2007) showed that shaping could increase on-task engagement in students. Further extension to things such as workplace productivity or quality improvement would also seem straightforward. Addressing broader goals (e.g., education and health promotion) that are made up of multiple behaviors may be more difficult. The role that formalized shaping procedures, such as percentile schedules, can play in facilitating these is an important area of future endeavor. Shaping can play an important role in facilitating abstinence in CM by capturing small increases in abstinence and increasing the future probability of prolonged abstinence.
